CV1 A Cost-Utility Analysis of Prophylactic Therapy for Venous Thromboembolism with Dabigatran Etexilate or Enoxaparin
2011 ◽
Vol 14
(7)
◽
pp. A535
X. Burbano-Levy
◽
S. Herrán
◽
G. Sánchez
◽
K. Mieth
◽
R. Alfonso-Cristancho
2004 ◽
Vol 124
(8)
◽
pp. 507-517
◽
Patrick Haentjens
◽
Katrien De Groote
◽
Lieven Annemans
2019 ◽
Vol 27
(2)
◽
pp. 627-634
Mohammadreza Amirsadri
◽
Sarah Mousavi
◽
Ali Karimipour
2013 ◽
Vol 16
(6)
◽
pp. 909-921
◽
Amelia Compagni
◽
Alessia Melegaro
◽
Rosanna Tarricone
2010 ◽
Vol 13
(3)
◽
pp. A166
R Pereira
◽
A Diamantopoulos
◽
J Bielik
◽
M Lees
◽
D Tomek
◽
...
Dalia M. Dawoud
◽
David Wonderling
◽
Jessica Glen
◽
Sedina Lewis
◽
Xavier L. Griffin
◽
...
2018 ◽
Vol 21
◽
pp. S107-S108
D. Dawoud
◽
D. Wonderling
◽
S. Lewis
◽
J. Glen
◽
X. Griffin
◽
...
2015 ◽
Vol 18
(7)
◽
pp. A395
S Stern
◽
F Cotte
◽
R Minacori
◽
T Gosden
◽
M Hamilton
◽
...
V. Pohjolainen
◽
P. Rasanen
◽
R. P. Roine
◽
H. Sintonen
◽
K. Wahlbeck
◽
...